DP

Dusan Perovic

Partner at Two Sigma Ventures

New York, New York

Overview 

Dusan Perovic is a Partner at Two Sigma Ventures in New York, with a background in investment banking, asset management, and corporate development. He has successfully invested in companies like Gameto (Series B) and Hexagon Bio (Series B), showcasing a strong track record in venture capital and alternative investments.

Work Experience 

  • Board Observer

    2024 - Current

  • Partner

    2016

Two Sigma Ventures is an early-stage venture capital fund that invests in companies run by highly driven people.

  • Board Member

    2024

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

Raised $73,000,000.00 from Yes VC, Jack Abraham, Two Sigma Ventures, SALT Fund, Myelin VC, Plum Alley, Chelsea M.R. Hirschhorn, FJ Labs, Insight Partners and TA Ventures.

  • Investor

    2024

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.

Raised $1,000,000,000.00 from Lux Capital, SV Angel, Two Sigma Ventures, F-Prime Capital, R-Squared Ventures, Foresite Capital, Byers Capital, ARCH Venture Partners, Lightspeed Venture Partners and New Enterprise Associates.

  • Board Member

    2019

Terray Therapeutics is a biotechnology company that transforms small molecule drug discovery.

Raised $200,000,000.00 from What If Ventures, Digitalis Ventures, NVentures, Goldcrest Capital, XTX Ventures, Alexandria Venture Investments, Madrona, Maverick Capital, Two Sigma Ventures and Bedford Ridge Capital.

  • Investor

    2018

Insitro is a drug discovery and development startup that utilizes machine learning and biology to transform drug discovery.

Raised $643,000,000.00 from Alexandria Venture Investments, BlackRock, HOF Capital, CPP Investments, Google Ventures, Foresite Capital, Casdin Capital, Temasek Holdings, T. Rowe Price and Third Rock Ventures.

  • Board Observer

    2020

Hexagon Bio is a data-driven biotech company developing targeted small molecule therapeutics.

Raised $193,600,001.00 from Two Sigma Ventures, The Column Group, Nextech Invest, 8VC, CPP Investments and ATEL Growth Capital.

  • Board Member

    2022

Freeform is a 3D printing company offering metal 3D printing solutions for manufacturing companies.

Raised $59,000,000.00 from NVentures, AE Industrial Partners, Two Sigma Ventures, Threshold, Founders Fund and 10x Founders.

  • Board Member

    2020

  • Board Observer

    2021

Exai Bio is an orphan non-coding RNAs and AI-based liquid biopsy company.

Raised $67,500,000.00 from Section 32, Casdin Capital and Two Sigma Ventures.

Articles About Dusan

Relevant Websites